| 000 | 01123 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513102105.0 | ||
| 264 | 0 | _c19961212 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0114-5916 | ||
| 024 | 7 |
_a10.2165/00002018-199614020-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrater, D C | |
| 245 | 0 | 0 |
_aBenefits and risks of torasemide in congestive heart failure and essential hypertension. _h[electronic resource] |
| 260 |
_bDrug safety _cFeb 1996 |
||
| 300 |
_a104-20 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aSulfonamides _xadverse effects |
| 650 | 0 | 4 | _aTorsemide |
| 773 | 0 |
_tDrug safety _gvol. 14 _gno. 2 _gp. 104-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00002018-199614020-00005 _zAvailable from publisher's website |
| 999 |
_c8846693 _d8846693 |
||